SPDR S&P Biotech ETF $XBI Shares Sold by Bristlecone Advisors LLC

Bristlecone Advisors LLC cut its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 31.2% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 16,453 shares of the exchange traded fund’s stock after selling 7,447 shares during the quarter. Bristlecone Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,364,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in XBI. DHJJ Financial Advisors Ltd. acquired a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at about $25,000. Garrison Bradford & Associates Inc. acquired a new stake in SPDR S&P Biotech ETF during the 1st quarter worth approximately $39,000. Compass Wealth Management LLC lifted its position in SPDR S&P Biotech ETF by 46.0% during the 1st quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock worth $51,000 after acquiring an additional 200 shares during the period. Golden State Wealth Management LLC lifted its position in SPDR S&P Biotech ETF by 100.0% during the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock worth $52,000 after acquiring an additional 319 shares during the period. Finally, Quaker Wealth Management LLC lifted its position in SPDR S&P Biotech ETF by 101.2% during the 2nd quarter. Quaker Wealth Management LLC now owns 623 shares of the exchange traded fund’s stock worth $52,000 after acquiring an additional 53,536 shares during the period.

SPDR S&P Biotech ETF Trading Up 0.4%

SPDR S&P Biotech ETF stock opened at $112.00 on Wednesday. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $112.43. The stock has a 50 day moving average of $98.97 and a two-hundred day moving average of $88.51. The stock has a market capitalization of $6.87 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.